Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
173.89
-1.01 (-0.58%)
At close: Apr 2, 2026, 4:00 PM EDT
172.00
-1.89 (-1.09%)
After-hours: Apr 2, 2026, 7:44 PM EDT
CRL Employees
Charles River Laboratories International had 19,700 employees as of December 31, 2025. The number of employees decreased by 400 or -1.99% compared to the previous year.
Employees
19,700
Change (1Y)
-400
Growth (1Y)
-1.99%
Revenue / Employee
$203,826
Profits / Employee
-$7,327
Market Cap
8.56B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 19,700 | -400 | -1.99% |
| Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
| Dec 31, 2023 | 21,800 | 400 | 1.87% |
| Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
| Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
| Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
| Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
| Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
| Dec 30, 2017 | 11,800 | 800 | 7.27% |
| Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
| Dec 26, 2015 | 8,600 | 700 | 8.86% |
| Dec 27, 2014 | 7,900 | 200 | 2.60% |
| Dec 28, 2013 | 7,700 | 500 | 6.94% |
| Dec 29, 2012 | 7,200 | 100 | 1.41% |
| Dec 31, 2011 | 7,100 | -400 | -5.33% |
| Dec 25, 2010 | 7,500 | -500 | -6.25% |
| Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
| Dec 27, 2008 | 9,000 | 500 | 5.88% |
| Dec 29, 2007 | 8,500 | 500 | 6.25% |
| Dec 30, 2006 | 8,000 | -400 | -4.76% |
| Dec 31, 2005 | 8,400 | 400 | 5.00% |
| Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
| Dec 27, 2003 | 4,500 | -500 | -10.00% |
| Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
| Dec 29, 2001 | 4,000 | 500 | 14.29% |
| Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 41,900 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| RadNet | 9,276 |
| Medpace Holdings | 6,200 |
| Qiagen | 5,967 |
CRL News
- 24 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 4 weeks ago - Charles River Laboratories to Present at TD Cowen and Barclays Conferences - Business Wire
- 5 weeks ago - Charles River raises annual profit view as it sells underperforming assets - Reuters
- 5 weeks ago - Charles River Laboratories Provides Update on Planned Divestitures - Business Wire
- 6 weeks ago - Charles River Laboratories International, Inc. (CRL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Charles River Laboratories Q4 Review: Approaching A Bottom - Seeking Alpha
- 6 weeks ago - Charles River forecasts upbeat 2026 profit on improved demand for drug development services - Reuters